Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 29Uterine Cervical Neoplasms 23Endometrial Neoplasms 14Breast Neoplasms 10Neoplasms 8Uterine Cervical Dysplasia 5Carcinoma, Ovarian Epithelial 5Peritoneal Neoplasms 4Papillomavirus Infections 4Lung Neoplasms 4Fallopian Tube Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Hereditary Breast and Ovarian Cancer Syndrome 3Disease 3Uterine Neoplasms 2Prostatic Neoplasms 2Primary Ovarian Insufficiency 2Ovarian Diseases 2Melanoma 2Leukemia 2Kidney Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Hyperplasia 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arachnodactyly × Blood Specimen Collection × Gynecologic × Clear all
NCT00436189 2008-04-30

Assess Cancer in Ovarian Tumors With Biomarkers.

Ciphergen Biosystems

Phase NA Completed
1,000 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms, Arachnodactyly

Data powered by HemOnc (CC BY 4.0) Colophon âš¡